Affiliate of Centre for Extracellular Vesicle Nanomedicine
Centre for Extracellular Vesicle Nanomedicine
Faculty of Health, Medicine and Behavioural Sciences
Professor
School of Pharmacy and Pharmaceutical Sciences
Faculty of Health, Medicine and Behavioural Sciences
Availability:
Available for supervision
Research Interests
Advanced Drug Delivery and Nanomedicine 1.Advanced drug delivery methods (controlled release dosage forms such as tablets, granules and microspheres) 2. Biomaterials as next generation adjuvant for vaccine delivery 3. Surface modified nanomaterials (Silica, Polymer, Liposomes) 4. Programmable nanoparticales for oral drug delivery and targeting 5. Translocation of nanoparticles after oral drug delivery (In-vitro and In-vivo)
Qualifications
Master of Pharmaceutical Science, Gujarat University
Australian Institute for Bioengineering and Nanotechnology
Availability:
Available for supervision
Scaling-up fermentation processes is not straightforward due to the emergence of concentration gradients at scale. For gas fermentation processes, with CO2, CO and CH4 and H2, scaling is even more challenging as high mass transfer rates need to be obtained. In his work, Lars is developing a framework to reliably scale-up gas fermentation processes, considering both mass transfer and concentration gradients. We aim to employ mechanistic models, combined with wet-lab data, to develop relationships and fluid dynamic (CFD) models to estimate the fermentation performance at industrial scale. He specialised in topics like bioreactor and bioprocess design, bioprocess scale-up/scale-down, mass transfer and transport phenomena, metabolic and kinetic modelling and simulation techniques.
Faculty of Engineering, Architecture and Information Technology
NHMRC Emerging Leadership Fellow
Australian Institute for Bioengineering and Nanotechnology
Availability:
Available for supervision
Dr. Wang completed her MPhil study in the University of Queensland (UQ) in 2016 and PhD study in UQ in October 2020. As an early career researcher, Dr.Wang has demonstrated a high impact track record relative to opportunity with award of Dean's award for Excellence in Higher Degree Research (2016), the high proportion (41%) of first-authored publications, 28% of which in the top 10% most cited publications worldwide (Scopus 24/03/2021). She has been actively engaged in a number of professional activities in the research fields, including RHD student supervision, assessment for the master research projects (BIOX7021), talks at national and international conferences (The Australian Colloid and Interface Symposium Brisbane hub, 2021; The Australasian Society for Stem Cell Research ECR Symposium, 2021; BioNano Innovation, 2020) and conference organization (The Australian Colloid and Interface Symposium Brisbane hub, 2021).
